10-Q: Medicale Corp. Q1 Loss Narrows Amidst Going Concern

Medicale Corp. reported a reduced net loss for Q1 2026, but faces significant going concern doubts and ineffective internal controls as it remains pre-operational.

Summary

• Medicale Corp. reported a net loss of $5,290 for the three months ended December 31, 2025, a 68% reduction from the $16,680 net loss in the prior year period.
• Operating expenses decreased significantly by 79% to $3,144, primarily due to lower audit fees.
• Interest expense increased by 27% to $2,146 for the quarter.
• The company has an accumulated deficit of $222,288 and a working capital deficit of $32,202 as of December 31, 2025.
• Cash and cash equivalents remained at $0 as of December 31, 2025.
• The company continues to rely on financing activities, raising $6,740 from the issuance of convertible notes during the quarter to cover operating expenses.
• Management has identified substantial doubt about the company's ability to continue as a going concern.
• Disclosure controls and procedures were deemed ineffective due to a lack of segregation of duties, with the sole officer and director performing all financial functions without independent review.
• The company has not yet commenced any operations and has not generated revenue from its business activities, which are planned to include consulting services and dietary supplement distribution.

Sentiment

Score: 1

Explanation: StockSavvy.ai views this as highly negative due to the company's pre-revenue status, ongoing going concern issues, zero cash balance, and critical internal control deficiencies, indicating severe operational and financial instability.

Positives

• Net loss significantly decreased by 68% to $5,290 for the three months ended December 31, 2025, compared to $16,680 in the same period last year.
• Operating expenses decreased by 79% to $3,144, primarily due to a reduction in audit fees.
• Net cash used in operating activities decreased to $6,740 from $10,000 in the prior year period.

Negatives

• The company has an accumulated deficit of $222,288 and a working capital deficit of $32,202 as of December 31, 2025.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company has not yet commenced any operations and has not generated any revenue since its inception.
• Cash and cash equivalents are $0 as of December 31, 2025.
• Disclosure controls and procedures were not effective due to a lack of segregation of duties, with the sole officer and director handling all financial functions without independent oversight.
• Interest expense increased by 27% to $2,146 for the quarter.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern, as it has not established a stabilized source of revenues sufficient to cover operating costs.
• Dependence on additional investment capital to fund operating expenses, with no assurances of successful fundraising.
• Inherent problems, expenses, delays, and risks associated with establishing a new business enterprise, including limited capital resources, possible changes in consumer interest, and potential cost overruns.
• Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially.
• Ineffective disclosure controls and procedures due to a lack of segregation of duties, increasing the risk of errors or fraud in financial reporting.

Future Outlook

Management anticipates that the company will be dependent on additional investment capital to fund operating expenses for the near future. The company intends to position itself to raise additional funds through the capital markets, but there are no assurances of success or financial viability. The company plans to offer consulting services and distribute dietary supplements but has not yet commenced these operations.

Management Comments

• "We have not generated revenue from our business operations. Furthermore, as we are still in the early stages of developing our business and expect to operate at a loss as we grow our business."
• "There is little historical financial information about our Company upon which to base an evaluation of our performance or to make a decision regarding an investment in our shares."
• "We cannot guarantee that we will be successful in our business operations or that we will achieve significant, if any, level of market acceptance for our proposed business operations and products."
• "As of the date of this report, the Company had not yet commenced any operations. All activity through the date of this report relates to preserving cash, attempting to raise capital, and continuing the Company's public reporting."
• "Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses."
• "The Company intends to position itself so that it will be able to raise additional funds through the capital markets."

Industry Context

StockSavvy.ai notes that Medicale Corp. operates in the highly competitive and regulated dietary supplement and consulting services industries. Its pre-revenue status and reliance on capital raises for basic operations place it significantly behind established players and even many early-stage startups that have demonstrated initial product-market fit or revenue generation. The lack of operational commencement suggests it has not yet entered the competitive landscape.

Comparison to Industry Standards

• Medicale Corp.'s pre-revenue status and accumulated deficit of $222,288 are significantly below industry standards for operational companies in the dietary supplement or consulting sectors, which typically demonstrate revenue generation or substantial asset bases at this stage.
• The company's reliance on convertible notes for operating expenses and zero cash balance is indicative of a very early-stage or distressed entity, contrasting sharply with established industry players like GNC Holdings or Herbalife Nutrition, which have robust revenue streams and positive cash flows.
• The identified 'going concern' doubt is a critical red flag, not typically seen in financially stable or growing companies within these industries.
• The ineffective internal controls due to lack of segregation of duties are a severe governance deficiency, far below the standards expected of publicly traded companies, regardless of size, and would be a major concern for any institutional investor compared to peers with robust financial oversight.

Corporate Governance

Related Party Transactions

• The principal place of business at 9314 Forest Hill Blvd #929 Wellington, FL 33411 is provided to the company on a rent-free basis by its sole officer and director, Chen Zu De.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern doubts, pre-revenue status, accumulated deficit, and reliance on dilutive financing.
• Creditors (convertible note holders) are exposed to risk given the company's financial instability and dependence on future capital raises.
• Potential future employees, customers, and suppliers may be impacted by the company's inability to commence operations or achieve financial viability.

Next Steps

• Attempt to raise additional funds through the capital markets to fund operating expenses.
• Commence planned operations in consulting services and dietary supplement distribution.
• Address and remediate the identified deficiencies in disclosure controls and procedures, particularly regarding segregation of duties.

Key Dates

Recommendation

The company is pre-revenue, has a substantial accumulated deficit, zero cash, and significant going concern doubts. The identified material weakness in internal controls due to a lack of segregation of duties further exacerbates the risk profile. While the net loss decreased, it's primarily due to reduced audit fees, not operational improvement. The continuous reliance on dilutive convertible notes to fund basic operations, without any clear path to revenue generation, makes this a highly speculative and risky investment. A seasoned investor would likely divest to avoid further capital erosion.

Keywords

Medicale Corp, 10-Q, Quarterly Report, Going Concern, Pre-revenue, Dietary Supplements, Consulting Services, Financial Deficit, Convertible Notes, Internal Controls, SEC Filing